Related Experiment Video
Updated: Jul 16, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Common problems with antiretroviral therapy among three Swedish groups of HIV infected individuals
Amadou Jallow1, Sofia Kälvemark Sporrong, Lilian Walther-Jallow
1Apoteket Källan, Box 64, 14501 Norsborg, Sweden. amadou.jallow@apoteket.se
Insights
Combination antiretroviral therapy (CART) presents unique challenges for different HIV-positive groups in Sweden, including social stigma and medication management issues. Addressing these specific patient needs is crucial for improving treatment adherence and outcomes.
Area of Science:
- Public Health
- Infectious Diseases
- Pharmacology
Background:
- HIV infection remains a significant global health concern.
- Combination antiretroviral therapy (CART) is the cornerstone of HIV management.
- Understanding patient-reported challenges is vital for optimizing treatment adherence and outcomes.
Purpose of the Study:
- To identify and compare common problems faced by distinct HIV-positive populations undergoing CART in Sweden.
- To investigate challenges experienced by homo- or bisexual individuals, former injecting drug users, and individuals of Sub-Saharan African origin.
Main Methods:
- A problem detection study (PDS) was employed.
- In-depth interviews informed questionnaire design.
- 195 HIV-positive patients in major Swedish cities participated, yielding a 79% response rate.
Main Results:
- Common issues across all groups included public stigma, concerns about disease progression or treatment failure, medication-related problems, and pharmacy visit difficulties.
- Specific challenges varied: homo- or bisexual individuals faced drug-related issues (adverse effects, pill burden), former injecting drug users dealt with family conflicts and psychosocial burdens, and individuals of African origin feared medication exposure revealing their HIV status.
Conclusions:
- Findings highlight the need for tailored pharmacy care for diverse HIV-positive patient groups.
- General adherence strategies must be supplemented with group-specific interventions.
- Further research on interventions promoting concordance and adherence is essential to prevent treatment failure and viral resistance.
Objective:
The main objective of this study was to identify and compare the common problems and difficulties associated with combination antiretroviral therapy (CART) as experienced by three major groups of HIV infected individuals (homo- or bisexuals, former injecting drug users and origins of Sub-Saharan Africa) in Sweden.
Methods:
Based on the results from in-depth interviews with 15 representatives from the three major groups, a questionnaire was designed for use in a problem detection study (PDS). The study was conducted with 195 HIV-positive patients residing in the major cities of Sweden.
Results:
The overall response rate was 79%. The problems identified in all three groups were negative attitudes from the public, worries about disease progression or therapy failure, medication or drug-related problems and problems in connection to pharmacy visits. A specific problem in the homo- or bisexual group was drug-related problems such as adverse effects, drug interactions and pill burden. For former injecting drug users, the specific problem was disease-related conflicts with relatives and the problem of coping with the social and psychological burden caused by the HIV infection. The African group termed the risk of exposing their medication at the pharmacy as a specific problem, as this could reveal their HIV status.
Conclusions:
Our findings regarding problems with CART in three patient groups in Sweden may be of use to tailor pharmacy care to HIV infected individuals. General strategies to improve adherence need to be complemented with approaches that will address the specific needs for the different patient groups affected by HIV. Further studies on group-specific interventions that promote concordance and adherence to CART will be necessary to minimize therapy failure and viral resistance.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Inhibitors of Viral Protein Synthesis
Amebiasis
Cryptococcal Meningitis

